2 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Terminated 1 |
Follow Zemplar (paricalcitol injection): new trials by email Literature Review of Zemplar (paricalcitol injection) trials Research Report on Zemplar (paricalcitol injection)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection Hectorol (doxercalciferol capsules), Zemplar (paricalcitol injection) - Secondary Hyperparathyroidism | Phase 4 | Completed | Genzyme, a Sanofi Company | 36 | 2007-04-01 | 2015-05-05 |
| A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis Hectorol (doxercalciferol injection), Zemplar (Paricalcitol injection) - Secondary Hyperparathyroidism | Phase 4 | Completed | Genzyme, a Sanofi Company | 12 | 2007-02-01 | 2015-05-05 |
| Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis Zemplar (paricalcitol injection), Calcijex - End-Stage Kidney Disease | Phase 4 | Terminated | Abbott | 2200 | 2003-04-01 | 2006-08-02 |
Hyperparathyroidism, Secondary (2) · Kidney Failure, Chronic (1)
Genzyme, a Sanofi Company (2) · Abbott (1)
United States (3)